American Society of Clinical Oncology guidance statement: the cost of cancer care. - Wikidata - wikimedia - TriplyDB

American Society of Clinical Oncology guidance statement: the cost of cancer care.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

http://www.wikidata.org/entity/Q39965070

about

Critical care of patients with cancer The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions Health-Care Metrics in Oncology Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review Identifying specific chemotherapeutic agents in Medicare data: a validation study Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.Exploring public attitudes towards approaches to discussing costs in the clinical encounter.Communication with Physicians about Health Care Costs: Survey of an Insured Population American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting.Current challenges in health economic modeling of cancer therapies: a research inquiry.Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews.Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices.Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.Understanding patient perspectives on communication about the cost of cancer care: a review of the literature.Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncology A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial Patient experience and attitudes toward addressing the cost of breast cancer care.Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial.A copay foundation assistance support program for patients receiving intravenous cancer therapy.Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study PACE Continuous Innovation Indicators-a novel tool to measure progress in cancer treatments.Projections of the cost of cancer care in the United States: 2010-2020.The effect of care setting in the delivery of high-value colon cancer care Drug waste minimization as an effective strategy of cost-containment in oncology.National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008 Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014.Benchmarks for value in cancer care: an analysis of a large commercial population.The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial development.Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.When to wait for more evidence? Real options analysis in proton therapy.Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions Cancer care burden: aiming at the Achilles heel The economic pressures for biosimilar drug use in cancer medicine Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.

P2860

Q26746976-B9D34172-E8E6-466A-A9F2-AD08529F2DFD Q26770254-2F8CE0CC-BCBA-4C2B-A902-70AA8E14AB5C Q26785718-D5229B88-9F36-4498-B7B8-90DF7C867743 Q27313318-E0B0540F-C351-4C71-A083-C8F18A38FE22 Q28546685-2A3C6488-C6A0-4E3E-A724-3EF17C1DFB13 Q30393166-2224FA73-0820-4B07-A521-66ADFC5A6B13 Q30413422-E4E2A4A8-BCFF-485A-B34C-42A729FD872F Q30557710-AB39956D-6497-4523-A643-CA8DD4F8B4F0 Q30564143-9EFD68DE-090A-4568-8674-9B16B347AAA6 Q33564966-3B322321-5491-4726-8045-E35E4348C9BD Q33631047-B56F44AA-DB7D-4222-A9A2-62EA09B7DA65 Q33777485-F9528976-1C7D-4E3A-B6DF-AA5B5919EDBF Q33805471-6BCC2F71-C5F1-4140-B83F-974DF00E4E97 Q33814897-B8494A68-8977-42BF-A26B-B717126EAF86 Q33942677-CD937885-8C58-4AD1-8B5D-25EA6649C5D0 Q33955955-AB85FFFA-69AF-4B6B-B775-1B4EBB7AD2D5 Q33978909-9EC44545-419A-48ED-8B01-8BC89E3C139E Q34114926-31D902A0-B0C1-4CC3-9DA2-079C2C760907 Q34206726-89846731-E6BE-4027-BBD0-7386A04FA29F Q34457992-51C04A54-CD7E-485E-A33C-F96F9942BBF8 Q34497601-ECF0824B-3DCD-4E88-AD2F-2B0468B2B3E6 Q34615959-8C60CB4B-23E8-46E5-BFDF-88F98A42E960 Q34637989-FC6CC150-E791-4973-A938-A0919BD1B902 Q34996046-2E04E664-E7BE-42F8-8B46-48F4A2275DA8 Q35002591-273DE072-02F3-4259-916F-86E2F31C79F8 Q35022830-66143C4B-9EE8-46FF-8A1C-790010A1983E Q35077470-6CDAB7D6-8CEC-4ABD-AEF4-E7CC0A752D38 Q35089146-DF3F9FB8-316A-4183-9A66-8AA05D900BA7 Q35114551-5EFD93BC-B23E-46DF-864F-8B1D264B7254 Q35198347-25B6445A-1A51-4DF8-80C6-FAAB0F2C247E Q35205672-91AD5C29-3C60-4F9D-8C47-A8291FE88793 Q35573019-4EB4A5EE-A9C2-46C0-9E34-86D920EB7BE8 Q35583683-734845F0-65A1-4E82-AC18-33A8CE5835AF Q35625692-04D5C2E1-0F8A-4EDC-85A5-2106665E5A8F Q35642383-3764F3DA-BE01-4E10-B3EA-5B671DF5730B Q35671352-446052F1-E7A3-4BC8-B5D4-E0E1B7766613 Q35680875-A773D941-EEDB-4839-A514-F9C8534D29E8 Q35714571-76837A64-7D39-4F18-9C9A-DF5EF1077CF6 Q35795204-A1E3C9E6-7369-41CC-835C-0A78617FFA41 Q35866144-9D4E5B22-D6C1-42E2-8978-76EFDEB87F4F

P2860

American Society of Clinical Oncology guidance statement: the cost of cancer care.

http://www.wikidata.org/entity/Q39965070

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@en

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@nl

type

label

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@en

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@nl

prefLabel

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@en

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@nl

P1433

Q39965070-532E7928-9227-47B6-9BB5-4F22C9022161

P1476

Q39965070-AE01486C-5CE2-420D-B364-DA5C8A57A4AF

P2093

Q39965070-0AFF7730-7A82-4DF6-8E47-BE4DE755E89B

Q39965070-19FDE4DA-0C9D-44A0-A321-8AD010C08583

Q39965070-2273BECA-7045-4CF0-BD7C-B6A4DA4D0450

Q39965070-5033A40E-1255-4DEF-BEAA-960DA69DD9DC

Q39965070-5403DB15-A757-473B-AC79-E9A8F9DEEED7

Q39965070-66BBC2FF-9651-486D-859C-B802BBD2BD6A

Q39965070-EA9F7E4D-73D1-4521-A3E2-C0F9551FA736

Q39965070-EE764648-F4DB-4F6A-A07D-92D2EA3F7DEC

P304

Q39965070-909F8C91-B139-44E1-A216-E1DBEF71B4B5

P31

Q39965070-F184B118-DDEA-47B9-8258-FF71A056794D

P356

Q39965070-D427E73D-FCF6-458D-A546-F68406B309F0

P407

Q39965070-64920322-7AFE-4837-B6F0-680904C801FA

P433

Q39965070-A7ECF212-A77F-4453-B9E7-7A55528EE94E

P478

Q39965070-ECACA686-3240-4254-A3D9-37E41CB0CD04

P50

Q39965070-E270A657-1D93-42DD-9E05-F92776B0F6F6

P577

Q39965070-45DE9646-14BC-48B6-AA5E-28D18A36096F

P698

Q39965070-57148BF3-2F69-4F46-8536-2F0EA8ACAC5A

P356

JCO.2009.23.1183

P1433

Journal of Clinical Oncology

P1476

American Society of Clinical Oncology guidance statement: the cost of cancer care.

@en

P2093

Deborah Schrag

http://www.w3.org/2001/XMLSchema#string

Diane Blum

http://www.w3.org/2001/XMLSchema#string

Lowell E Schnipper

http://www.w3.org/2001/XMLSchema#string

Neal J Meropol

http://www.w3.org/2001/XMLSchema#string

Peter A Ubel

http://www.w3.org/2001/XMLSchema#string

Robert M Langdon

http://www.w3.org/2001/XMLSchema#string

Therese M Mulvey

http://www.w3.org/2001/XMLSchema#string

Thomas J Smith

http://www.w3.org/2001/XMLSchema#string

P304

3868-3874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.23.1183

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

American Society of Clinical Oncology

P577

2009-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19581533

http://www.w3.org/2001/XMLSchema#string